ReaderFunded · site

Onco'Zine

oncozine.com

Onco'Zine, “A part of the Oncology and Hematology News Network”, is a news site on oncozine.com, in English, funded by its readers through Patreon; no supporter count is published.

Visit Onco'ZineSupport on Patreon

Is this your site? There is a badge you can show, with the live figure.

Pages

519 pages indexed; the pages that lead the site by its internal links:

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the 'War' Against Cancer - Onco'Zine
https://oncozine.com/reversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer/
Thalidomide's Secret Past: The Link with Nazi Germany - Onco'Zine
https://oncozine.com/thalidomides-secret-past-the-link-with-nazi-germany/
What to Expect at ASCO 2026 —Translating Science to Practice - Onco'Zine
https://oncozine.com/what-to-expect-at-asco-2026-translating-science-to-practice/
A Vaccine Built From a Single Patient's Tumor: What the INTerpath-001 Melanoma Results Mean - Onco'Zine
https://oncozine.com/a-vaccine-built-from-a-single-patients-tumor-what-the-interpath-001-melanoma-results-mean/
Two Personalized Cancer Vaccine Trials, Two Very Different Results - Onco'Zine
https://oncozine.com/two-personalized-cancer-vaccine-trials-two-very-different-results/
Detect Cancer Early: Liquid Biopsy Based ctDNA Methylation as a Promising Diagnostic Approach - Onco'Zine
https://oncozine.com/detect-cancer-early-liquid-biopsy-based-ctdna-methylation-as-a-promising-diagnostic-approach/
A Third CD38 Antibody, and a New Player: What Felzartamab's China Approval Means for the Multiple Myeloma Market - Onco'Zine
https://oncozine.com/a-third-cd38-antibody-and-a-new-player-what-felzartamabs-china-approval-means-for-the-multiple-myeloma-market/
It’s Time to Stop Talking About Cellular Therapy Disparities and Take Action - Onco'Zine
https://oncozine.com/its-time-to-stop-talking-about-cellular-therapy-disparities-and-take-action/
Are Price Controls Disrupting Clinical Trials and Stifling Medical Innovation? - Onco'Zine
https://oncozine.com/are-price-controls-disrupting-clinical-trials-and-stifling-medical-innovation/
Pfizer Agrees to Acquire Seagen for US $ 43 Billion - Onco'Zine
https://oncozine.com/pfizer-agrees-to-acquire-seagen-for-us-43-billion/
‘They Won’t Help Me’: Sickest Patients Face Insurance Denials Despite Policy Fixes - Onco'Zine
https://oncozine.com/they-wont-help-me-sickest-patients-face-insurance-denials-despite-policy-fixes/
Rusfertide, the First Hepcidin Mimetic for the treatment of Polycythemia Vera (PV) is Approved by the U.S. FDA - Onco'Zine
https://oncozine.com/rusfertide-the-first-hepcidin-mimetic-for-polycythemia-vera-pv-is-approved-by-the-u-s-fda/

Standing

category newslang enrank 42995 of 94631paying not publishedrevenue / yr not publishedno supporter count: the floor weight

Verified funding

Badge

For the site's owner: a badge that says readers fund it, linked to this page. It shows the live figure, so it never goes stale; a count appears once a platform publishes one.

Reader-funded, verified by ReaderFunded

HTML

<a href="https://readerfunded.com/site/oncozine.com"><img src="https://readerfunded.com/badge/oncozine.com.svg" alt="Reader-funded, verified by ReaderFunded" height="20"></a>

Markdown

[![Reader-funded, verified by ReaderFunded](https://readerfunded.com/badge/oncozine.com.svg)](https://readerfunded.com/site/oncozine.com)

Neighbourhood

Linked from 159 domains, links to 1,858; of the latter, the funded sites are shown. Funded sites first, then the sources that link to fewest other funded sites. Links as seen in the Common Crawl domain graph (cc-main-2026-aug-sep-oct), cut 2026-10-23: the pages crawled in a window of three months, not necessarily the site of today, and a page not crawled in that window leaves no link.

Linked from
Links to funded sites

Similar funded sites

Sites the same sources link to, by cosine over the sets of linking domains. More.

The Going North Podcast
goingnorthpodcast.com
podcast · en · tier B · 3 paying (Buy Me a Coffee) · 2 shared · 0.01
Science 2.0
science20.com
science · en · tier C · 0 paying (Patreon) · 11 shared · 0.00
vator.tv
· 4 shared · 0.00
The Medical Futurist
medicalfuturist.com
health · en · tier A · 67 paying (Patreon) · 7 shared · 0.00
Sludge
readsludge.com
news · en · tier A · 10 paying (Patreon) · 4 shared · 0.00
bugzilla.org
tech · en · tier A · 5 paying (GitHub Sponsors) · 2 shared · 0.00
mychesco.com
news · en · tier B · 5 shared · 0.00
captivate.fm
podcast · en · tier A · 281 paying (Patreon) · 6 shared · 0.00
castos.com
podcast · en · tier B · 6 paying (Buy Me a Coffee) · 4 shared · 0.00
newsminimalist.com
general · en · 2 shared · 0.00
The Odin Project
theodinproject.com
education · en · tier A · 95 paying (Open Collective) · 2 shared · 0.00
Silent Lunch
silentlunch.net
general · en · tier B · 2 shared · 0.00